Cargando…
伊布替尼治疗复发/难治原发性自身免疫性溶血性贫血二例——探索性研究
OBJECTIVE: To explore the efficacy and safety of ibrutinib treatment for relapsed/refractory（R/R）primary autoimmune hemolytic anemia（AIHA）. METHODS: Two cases of primary AIHA with relapse events were refractory to glucocorticoid, anti-CD20 monoclonal antibody, immunosuppressive drugs, and splenectom...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342072/ https://www.ncbi.nlm.nih.gov/pubmed/32536139 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.05.009 |